Nutrição e Osteoporose – Artigo 13

Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses Numerous studies suggested that oxidative stress (OS) played a central role in the onset and development of postmenopausal osteoporosis (PO); however, conflicting results were obtained as to the association of OS-related biomarkers and PO. This metaanalysis aimed to identify the association between these markers and PO, and explore ...

Nutrição e Osteoporose – Artigo 12

Osteoporosis and Sarcopenia in Older Age Abstract Osteoporosis and sarcopenia are common in older age and associated with significant morbidity and mortality. Consequently, they are both attended by a considerable socioeconomic burden. Osteoporosis was defined by the World Health Organisation (WHO) in 1994 as a bone mineral density of less than 2.5 standard deviations below the sex-specific young adult mean and this characterisation has ...

Nutrição e Osteoporose – Artigo 11

Osteoporosis and fracture risk in older people Introduction Until the 1940s, when Albright associated osteoporosis with a defect of bone anabolism, it was not considered a disease entity but an inevitable consequence of the ageing process for which there was little remedy.1 Bisphosphonates, first synthesised in the 1800s but in clinical use only since the 1960s, demonstrated that this process of age-related decline in bone was, in ...

Nutrição e Osteoporose – Artigo 10

Nutrition and osteoporosis prevention for the orthopaedic surgeon: a wholefoods approach Introduction Osteoporosis is a silent but progressive disease affecting the density and quality of bone while greatly increasing fracture risk.1 Globally, around one in three women and one in five men are at risk of an osteoporotic fracture, with the most common fractures being at the hip, spine or wrist.1 The pathogenesis of osteoporosis is ...

Nutrição e Osteoporose – Artigo 9

Managing Osteoporosis Patients after Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research Abstract Bisphosphonates (BPs) are the most commonly used medications for osteoporosis, but optimal duration of therapy is unknown. This ASBMR report provides guidance on BP therapy duration with a risk benefit perspective. Two trials provided evidence for long-term BP use. In the Fracture ...

Nutrição e Osteoporose – Artigo 8

Management of Osteoporosis in Chronic Kidney Disease Abstract: Chronic kidney disease (CKD) patients with coexisting osteoporosis are becoming common. Many of the  therapeutic agents used to treat osteoporosis are known to be affected by the renal function. It is generally thought that osteoporosis in G1 to G3 CKD patients can be treated as in non-CKD patients with osteoporosis. In stage 4 or more advanced CKD patients and CKD patients on ...

Nutrição e Osteoporose – Artigo 7

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates Abstract Background—Low adherence to oral bisphosphonates is a common problem that jeopardizes the efficacy of treatment of osteoporosis. No clear screening strategy for the assessment of compliance is widely accepted in these patients. Methods—The International Osteoporo...

Nutrição e Osteoporose – Artigo 6

Effects of whole body vibration exercises on bone mineral density of women with postmenopausal osteoporosis without medications: novel findings and literature review Abstract Objectives: The aim of this study was to review the literature about the effect of whole body vibration exercise in the BMD in patients with postmenopausal osteoporosis without medications. Methods: A systematic review was performed. Results: The frequency of the ...